Baxter Receives U.S. FDA Approval for 0.9% Sodium Chloride Injection, USP from Sabinanigo, Spain, Facility for the U.S. Market DEERFIELD, Ill., May 15, 2015 - Baxter International Inc. (NYSE: BAX) ...
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals LLC announced it has received U.S. Food and Drug Administration (FDA) approval for 0.9% Sodium Chloride Injection, USP in 10mL and 20mL ...
New low concentration options in Freeflex ® IV bags join broadest portfolio of heparin sodium therapies LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced in the ...
Brand(s): Sodium Chloride Injection Hypertonic, Baxter Injection, for 2.5 mEq of Sodium Chloride Additive preparation of Na+/mL and Solution, Abraxis IV admixtures Cl-/mL pharmacy bulk package 4 mEq ...
Baxter International Inc has initiated a voluntary recall of 1 lot of 5% dextrose injection and 4 lots of 0.9% sodium chloride injection intravenous (IV) solutions because of the presence of ...
- Nine Heparin Vials to be Differentiated with PreventIV Measures(TM) Packaging and Labeling Features - Download image SCHAUMBURG, Ill., July 1 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a ...